11 March 2026
March BNF + BNFC Knowledge Updates
British National Formulary
This update contains 3 significant changes, 1 new monograph, 2 new preparations, and 1 deleted monograph.
Significant changes
Antibacterials, use for prophylaxis: updated guidance for endoscopic retrograde cholangiopancreatography, transrectal prostate biopsy, and transurethral resection of prostate.
Migraine: updated guidance on management.
Obeticholic acid: new guidance for use in hepatic impairment.
New monographs
Blenrep® [belantamab mafodotin] for Multiple myeloma.
New preparations
Ocrevus® [ocrelizumab] for Multiple sclerosis (specialist use only).
Vevizye® [ciclosporin] for Moderate to severe dry eye disease that has not responded adequately to treatment with tear substitutes (initiated by a specialist).
Deleted monographs
Felbinac.
BNF for Children
This update contains 2 significant changes.
Significant changes
Antibacterials, use for prophylaxis: updated guidance for endoscopic retrograde cholangiopancreatography.
Supply of medicines: updated guidance on labelling of prescribed medicines.
